An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)
Clinical trial NCT05112965 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05112965
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2027-06-30
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.